Search research articles
Contact Us
Filters
Showing results (41-50 of 160) with videos related to
Page
of 16
Sort By:
Addictive Disorders & Their Treatment
|
May 16, 2017
Age and gender considerations for technology-assisted delivery of therapy for substance use disorder treatment: A patient survey of access to electronic devices
Denis Antoine, Sean Heffernan, Amina Chaudhry, et al.
Drug and Alcohol Dependence
|
May 23, 2007
Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone
James Rosado, Sharon L Walsh, George E Bigelow, et al.
Journal of Addiction Medicine
|
October 5, 2013
Gender differences in substance abuse treatment and barriers to care among persons with substance use disorders with and without comorbid major depression
Lian-Yu Chen, Eric C Strain, Rosa M Crum, et al.
Journal of Substance Abuse Treatment
|
April 3, 2007
Comparison of demographic and clinical characteristics between opioid-dependent individuals admitted to a community-based treatment setting and those enrolled in a research-based treatment setting
C Patrick Carroll, Michael Kidorf, Eric C Strain, et al.
Addictive Disorders & Their Treatment
|
September 28, 2011
Screening for Mood Disorder in Pregnant Substance-dependent Patients
Margaret S Chisolm, Michelle Tuten, Eric C Strain, et al.
Psychopharmacology
|
July 3, 2007
Modest opioid withdrawal suppression efficacy of oral tramadol in humans
Michelle R Lofwall, Sharon L Walsh, George E Bigelow, et al.
Addictive Disorders & Their Treatment
|
January 12, 2016
Recruitment techniques for alcohol pharmacotherapy clinical trials: A cost-benefit analysis
D Andrew Tompkins, Jessica A Sides, Joseph A Harrison, et al.
Addiction (Abingdon, England)
|
June 15, 2018
What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?
Brian D Kiluk, Garrett M Fitzmaurice, Eric C Strain, et al.
Clinical Pharmacology and Therapeutics
|
December 13, 2023
Reply to "Capturing Synergy Holistically in Psychedelic Clinical Trials"
Robert H Dworkin, Michael P McDermott, Sandeep M Nayak, et al.
Frontiers in Psychiatry
|
October 17, 2019
A Systematic Review of Laboratory Evidence for the Abuse Potential of Tramadol in Humans
Kelly E Dunn, Cecilia L Bergeria, Andrew S Huhn, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 160) with videos related to
Sort By:
Page
of 16
Addictive Disorders & Their Treatment
|
May 16, 2017
Age and gender considerations for technology-assisted delivery of therapy for substance use disorder treatment: A patient survey of access to electronic devices
Denis Antoine, Sean Heffernan, Amina Chaudhry, et al.
Drug and Alcohol Dependence
|
May 23, 2007
Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone
James Rosado, Sharon L Walsh, George E Bigelow, et al.
Journal of Addiction Medicine
|
October 5, 2013
Gender differences in substance abuse treatment and barriers to care among persons with substance use disorders with and without comorbid major depression
Lian-Yu Chen, Eric C Strain, Rosa M Crum, et al.
Journal of Substance Abuse Treatment
|
April 3, 2007
Comparison of demographic and clinical characteristics between opioid-dependent individuals admitted to a community-based treatment setting and those enrolled in a research-based treatment setting
C Patrick Carroll, Michael Kidorf, Eric C Strain, et al.
Addictive Disorders & Their Treatment
|
September 28, 2011
Screening for Mood Disorder in Pregnant Substance-dependent Patients
Margaret S Chisolm, Michelle Tuten, Eric C Strain, et al.
Psychopharmacology
|
July 3, 2007
Modest opioid withdrawal suppression efficacy of oral tramadol in humans
Michelle R Lofwall, Sharon L Walsh, George E Bigelow, et al.
Addictive Disorders & Their Treatment
|
January 12, 2016
Recruitment techniques for alcohol pharmacotherapy clinical trials: A cost-benefit analysis
D Andrew Tompkins, Jessica A Sides, Joseph A Harrison, et al.
Addiction (Abingdon, England)
|
June 15, 2018
What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?
Brian D Kiluk, Garrett M Fitzmaurice, Eric C Strain, et al.
Clinical Pharmacology and Therapeutics
|
December 13, 2023
Reply to "Capturing Synergy Holistically in Psychedelic Clinical Trials"
Robert H Dworkin, Michael P McDermott, Sandeep M Nayak, et al.
Frontiers in Psychiatry
|
October 17, 2019
A Systematic Review of Laboratory Evidence for the Abuse Potential of Tramadol in Humans
Kelly E Dunn, Cecilia L Bergeria, Andrew S Huhn, et al.
Page
of 16